Why is Granules India falling/rising?

As of 06-Aug, Granules India Ltd is currently priced at 439.30, reflecting a decline of 9.25 points or 2.06%. The stock has been experiencing a downward trend, having lost 3.12% over the last two days and is trading below all its moving averages, indicating weak momentum. Additionally, the stock's performance over the past week shows a significant drop of 10.37%, while its year-to-date performance is down 25.77%. Despite a high management efficiency indicated by a return on capital employed (ROCE) of 18.77% and strong debt servicing capabilities, the stock's long-term growth prospects appear poor, with net sales and operating profit growth rates of only 11.52% and 13.13%, respectively, over the last five years.
Broader Market Context: In comparison to the benchmark Sensex, which has declined by 1.15% over the past week, Granules India has significantly underperformed, indicating a more pronounced weakness in its stock price. The pharmaceutical sector, in which Granules operates, has also seen a decline of 2.06%, reflecting broader challenges within the industry. Furthermore, a notable decrease in investor participation, with delivery volume falling by 24.26% against the five-day average, suggests waning interest in the stock. Overall, the combination of poor short-term performance, weak sector trends, and declining investor engagement contributes to the stock's current downward trajectory.